Weekly Digest – November 2024 Weekly Digest – November 2024 21 Nov 2024: Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data PYX-201 demonstrated a confirmed 50% objective response rate (ORR) in heavily pretreated HNSCC patients, including […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id